Jianli Zhao

Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1

Yinghua Zhu, Yujie Liu, Chao Zhang et al. · Nature Communications · 2018 · 193 citations · Full text

Medicine, Oncology, Pharmacology +17

Endoscopic rhizotomy for chronic lumbar zygapophysial joint pain

Yuntao Xue, Tao Ding, Dajie Wang et al. · Journal of Orthopaedic Surgery and Research · 2020 · 25 citations · Full text

Medicine, Orthopedic Surgery, Surgery +11

Trastuzumab plus endocrine therapy or chemotherapy as first-line treatment for metastatic breast cancer with hormone receptor-positive and HER2-positive: The sysucc-002 randomized clinical trial.

Zhongyu Yuan, Jiajia Huang, Xin Hua et al. · Journal of Clinical Oncology · 2021 · 18 citations

Medicine, Oncology, Pharmacology +17

CHFR-mediated degradation of RNF126 confers sensitivity to PARP inhibitors in triple-negative breast cancer cells

Wenjing Wu, Jianli Zhao, Jianhong Xiao et al. · Biochemical and Biophysical Research Communications · 2021 · 10 citations

Life Sciences, Molecular Biology, Oncology +11